{"company": "AbbVie", "source": "Manual Map - AbbVie", "stats": {"entities": 121, "matched": 11, "snippets": 14}, "root": {"id": "abbvie-rd", "name": "AbbVie Research & Development", "type": "company", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "discovery-research", "name": "Discovery Research", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "So, I work with a, dermatologist, I'm in discovery research, our team, our team's an informatics team which we're in a different function.", "date": "2025-03-19", "gongUrl": "https://app.gong.io/call?id=32f862e749c365cc795543ec405f8666f41637007203eff6e6f7402b83237008", "callId": "2025-03-19_32f862e749c3", "customerName": "Kathleen Smith", "internalName": "Michelle Jang", "customerEmail": "kathleen.m.smith@abbvie.com", "internalEmail": "michelle.jang@biorender.com", "speakerId": "3977944264686211409", "sizeMentions": [], "contextBefore": "...4264686211409]: I find, the tools and the preloaded things so far have been adequate for what I need to do.\n[Speaker 3977944264686211409]: But, if I run across something I want, I don't know, I'm happy to let you know.\n[Speaker 9152211860076983320]: Okay.\n[Speaker 9152211860076983320]: Gotcha.\n[Speaker 9152211860076983320]: Certainly, that makes sense.\n[Speaker 9152211860076983320]: And then within kind of your internal presentations, I know that you said that, there's not a ton of usage for biorender with some of the biostatisticians.\n[Speaker 9152211860076983320]: Do you ever present cross functionally to other departments as a department?\n[Speaker 9152211860076983320]: Yes.\n[Speaker 9152211860076983320]: Okay.\n[Speaker 9152211860076983320]: So, so, in that sense, is there ever a need maybe for them to visualize, their data, or add any sort of figures or images just to make sure that message is getting across clear?\n[Speaker 3977944264686211409]: Yeah.\n[Speaker 3977944264686211409]: ", "contextAfter": "\n[Speaker 3977944264686211409]: And then I work with, early discovery, I work with the precision medicine team.\n[Speaker 3977944264686211409]: I work with, you know, I work with across the organization.\n[Speaker 3977944264686211409]: And so, if I could, for some of the findings we have, you know, if we have good visuals from our data, then that's fine.\n[Speaker 3977944264686211409]: But, if I, I've been told that we need to, you know, present things, the people like to look at the diagrams.\n[Speaker 3977944264686211409]: The problem I have with a lot of things people make is they put a bunch of garbage in there.\n[Speaker 3977944264686211409]: And then I don't like the figures, you know, they put, if you, it depends how you represent what's in the literature.\n[Speaker 3977944264686211409]: If you just take everything that's in the literature and make your figure, then half, at least half of it's going to be wrong.\n[Speaker 3977944264686211409]: So, I, I'm a little more, but people are u...", "callTitle": "BioRender & AbbVie - Intro Call"}], "confidence": "medium", "status": "auto_matched"}, "children": [{"id": "immunology-discovery", "name": "Immunology Discovery", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "dermatology-discovery", "name": "Dermatology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "I work primarily in dermatology, so skin diseases.", "date": "2025-06-13", "gongUrl": "https://app.gong.io/call?id=ac2d4c312e664e12ee6ff52aacb2884ae1589e08d4cfd03a312ca981185e6d6d", "callId": "2025-06-13_ac2d4c312e66", "customerName": "Kumar Krishnaswamy", "internalName": "Michelle Jang", "customerEmail": "kumar.krishnaswamy@abbvie.com", "internalEmail": "michelle.jang@biorender.com", "speakerId": "5786333041468561021", "sizeMentions": [], "contextBefore": "...ty good.\n[Speaker 5786333041468561021]: How are you?\n[Speaker 4588465079593939083]: I'm doing great too.\n[Speaker 4588465079593939083]: Thanks so much for asking.\n[Speaker 4588465079593939083]: Appreciate you finding some time to chat with me.\n[Speaker 4588465079593939083]: I know we spoke a little bit over email but just a brief intro on my side of things, I help support our app V, biorender users.\n[Speaker 4588465079593939083]: And we recently launched a new functionality within biorender that's been really useful for other teams at app V because they're industry specific.\n[Speaker 4588465079593939083]: So I was just hoping to learn a little bit more about how you're using biorender and to see if your group could benefit from any additional features or trainings and things of that nature.\n[Speaker 4588465079593939083]: Sure.\n[Speaker 5786333041468561021]: So I mean, I use biorender as most people do to create my figures for pathophysiology of diseases.\n[Speaker 5786333041468561021]: ", "contextAfter": "\n[Speaker 5786333041468561021]: So we use that for also looking at various cellular mediators and where our mechanism of action for drugs are.\n[Speaker 5786333041468561021]: So that's pretty much where I typically use it for.\n[Speaker 5786333041468561021]: I think it's the plugins for the, I like the older plugins, which was easier because it would connect into powerpoint.\n[Speaker 5786333041468561021]: It doesn't connect anymore to the new powerpoint as conveniently, but I think apart from that, I think it's a very useful tool.\n[Speaker 5786333041468561021]: And so typically, I have most of my templates and we share them within our colleagues because then they modify that for their use and such, it's pretty much how we use it.\n[Speaker 4588465079593939083]: So you're creating some visuals, there seems to be maybe a bit of collaboration in terms of people repurposing the images that you've created within biorender.\n[Speaker 4588465079593939083]: Curious about that powerpoint extension?...", "callTitle": "BioRender & AbbVie - Intro Call"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "gastroenterology-discovery", "name": "Gastroenterology & IBD", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "rheumatology-discovery", "name": "Rheumatology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "My team is rheumatology.", "date": "2025-04-15", "gongUrl": "https://app.gong.io/call?id=3a98a94b1db2a55adce89595dd1ffefc6172322579933c666128b716e1b2ab75", "callId": "2025-04-15_3a98a94b1db2", "customerName": "Mubaraka Sharif", "internalName": "Michelle Jang", "customerEmail": "mnusrat.sharif@abbvie.com", "internalEmail": "michelle.jang@biorender.com", "speakerId": "7776382201780527848", "sizeMentions": [], "contextBefore": "... into this right away, but for my needs, I'm pretty much able to use the limited version and go along.\n[Speaker 7776382201780527848]: But like, you know, I think like I'm going to talk with my manager and then, you know, I can let you know on that.\n[Speaker 7776382201780527848]: Yeah.\n[Speaker 5829362468422271377]: Yeah.\n[Speaker 5829362468422271377]: Okay.\n[Speaker 5829362468422271377]: Helpful for me to know.\n[Speaker 5829362468422271377]: And then we are already in discussion with departments and some departments are already scaled on.\n[Speaker 5829362468422271377]: In which case, I would just connect you with one of our colleagues to get you added on.\n[Speaker 5829362468422271377]: So, could you clarify for me which department specifically it is that you're a part of?\n[Speaker 7776382201780527848]: I'm discovery immunology discovery.\n[Speaker 5829362468422271377]: Immunology.\n[Speaker 5829362468422271377]: And is that the name of your immediate team?\n[Speaker 7776382201780527848]: ", "contextAfter": "\n[Speaker 5829362468422271377]: Rheumatology under the larger umbrella of discovery immunology.\n[Speaker 5829362468422271377]: Yeah.\n[Speaker 5829362468422271377]: Okay.\n[Speaker 5829362468422271377]: Fantastic.\n[Speaker 5829362468422271377]: I will go back and check on my end to see if we've had any conversations that would make it easier for us to just add you onto a larger central license.\n[Speaker 5829362468422271377]: If you do speak with your manager again, the demonstration and the trials and the webinars that comes at no cost to your group.\n[Speaker 5829362468422271377]: It's just, we already have a partnership with abbvie and we're trying to figure out which departments haven't had a chance to evaluate yet.\n[Speaker 5829362468422271377]: And so I help, oops, sorry just cut out for a second.\n[Speaker 5829362468422271377]: There.\n[Speaker 5829362468422271377]: I help oversee our relationship with abbvie.\n[Speaker 5829362468422271377]: But my colleague, Mike leads our partnership...", "callTitle": "BioRender & AbbVie - Intro Call"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "fibrosis-discovery", "name": "Fibrosis", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "oncology-discovery", "name": "Oncology Discovery", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 3, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "Oncology discovery?", "date": "2025-01-31", "gongUrl": "https://app.gong.io/call?id=a07c9ff5ae67f6d58e7d39a93c491d098e22906f7867153a45dcd42b5489512f", "callId": "2025-01-31_a07c9ff5ae67", "customerName": "Jason Kwon", "internalName": "Sierra Barnes", "customerEmail": "jason.kwon@abbvie.com", "internalEmail": "sierra.barnes@biorender.com", "speakerId": "29448528805148569", "sizeMentions": [], "contextBefore": "...7953]: So if somebody else on your team needs, that figure, you can kind of share it with them, They can create their own copy and kind of build off that Or you can both work collaboratively within BioRender.\n[Speaker 8367255805552897953]: It's kind of like Google Docs or Google Slides where you can kind of work on the same figure at the exact same time to kind of help streamline that process a little bit further.\n[Speaker 8367255805552897953]: Does that sound like it would be helpful at all?\n[Speaker 29448528805148569]: Yeah, I guess.\n[Speaker 29448528805148569]: Yeah.\n[Speaker 29448528805148569]: So I have a team of four people And yeah, at some point, it might be nice to know or if you could just email me how to sort of link some of the files and stuff so we can share it amongst ourselves.\n[Speaker 29448528805148569]: That'd be great.\n[Speaker 8367255805552897953]: Which department are you a part of Avila?\n[Speaker 8367255805552897953]: What's the name?\n[Speaker 29448528805148569]: ", "contextAfter": "\n[Speaker 8367255805552897953]: And is that only the four?\n[Speaker 8367255805552897953]: Is that group of four, a subgroup within oncology discovery?\n[Speaker 29448528805148569]: That's right?\n[Speaker 29448528805148569]: Yeah.\n[Speaker 29448528805148569]: So I'm sort of like a PI group leader.\n[Speaker 29448528805148569]: So the four work within my lab, and then we're nestled in, I guess if we were to use like parallels with academics, like a greater department.\n[Speaker 8367255805552897953]: Okay.\n[Speaker 8367255805552897953]: And do you guys collaborate with, you know, other PI pods, maybe across oncology discovery?\n[Speaker 8367255805552897953]: Or what does that look like?\n[Speaker 8367255805552897953]: Yeah, definitely.\n[Speaker 8367255805552897953]: Okay, perfect.\n[Speaker 8367255805552897953]: That's really helpful.\n[Speaker 29448528805148569]: If there's something like this, rarely would we ever need to share it between sort of TAs or cross functional groups?\n[Speaker 836725...", "callTitle": "BioRender & AbbVie - Intro Call"}, {"quote": "I'm in oncology discovery", "date": "2024-12-20", "gongUrl": "https://app.gong.io/call?id=f05a9b1251c2e63405ee63e84bd4e31453e9ff8fb6a4eb76dfb0ed328624f0b5", "callId": "2024-12-20_f05a9b1251c2", "customerName": "Marianne Palczewski", "internalName": "Sierra Barnes", "customerEmail": "marianne.b.palczewski@abbvie.com", "internalEmail": "sierra.barnes@biorender.com", "speakerId": "5743315185133101834", "sizeMentions": [], "contextBefore": "...and the flow and the, So we've built out templates to kind of help with building out of like the narrative of the presentation.\n[Speaker 408065496460366019]: So we kind of have all of those slides kind of built out.\n[Speaker 408065496460366019]: And then of course, everything is customizable.\n[Speaker 408065496460366019]: So you guys can like, you know, rearrange them, add in your own figures, add in your own text, but we're trying to like help streamline that process for you guys even further.\n[Speaker 408065496460366019]: But, yeah, kind of curious to get your thoughts on that.\n[Speaker 5743315185133101834]: Yeah, I feel like that would be, that would be very useful, Especially like if you hit a roadblock and what to kind of put on your slide.\n[Speaker 5743315185133101834]: That would be nice to have.\n[Speaker 5743315185133101834]: Yeah.\n[Speaker 408065496460366019]: Awesome.\n[Speaker 408065496460366019]: And which department are you part of at AbbVie?\n[Speaker 5743315185133101834]: ", "contextAfter": ".\n[Speaker 408065496460366019]: And how large is that team would you say?\n[Speaker 5743315185133101834]: To be honest, I don't know how big it is, Maybe between 50 and 100 people.\n[Speaker 5743315185133101834]: I'm not sure.\n[Speaker 408065496460366019]: Okay, perfect.\n[Speaker 408065496460366019]: And what are others on your team kind of currently using to build out the figures in their presentations and papers?\n[Speaker 5743315185133101834]: To be honest, I don't know.\n[Speaker 5743315185133101834]: I think a mix of Powerpoint and BioRender.\n[Speaker 5743315185133101834]: I mean, you know, of course, the, yeah, I guess for the visualization part.\n[Speaker 5743315185133101834]: Yeah, I think mostly just Powerpoint or BioRender.\n[Speaker 5743315185133101834]: Yeah, I don't know.\n[Speaker 408065496460366019]: Interesting.\n[Speaker 408065496460366019]: So you're seeing some people still kind of like manually building out figures in Powerpoint like from scratch.\n[Speaker 57433151851331018...", "callTitle": "BioRender & AbbVie - Intro Call"}, {"quote": "I want to say the entire organization is about 200 Like, Discovery Oncology.", "date": "2024-10-28", "gongUrl": "https://app.gong.io/call?id=3d374f2587a395063aa0a145a5783841cec06beee82a15519cb0f65e64145ab1", "callId": "2024-10-28_3d374f2587a3", "customerName": "Josh Plotnik", "internalName": "Katy Brenneman; Michael Stanfel; Nick DelRose; Samara Ona", "customerEmail": "joshua.plotnik@abbvie.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; nicholas.delrose@biorender.com; samara@biorender.com", "speakerId": "8583913747141573407", "sizeMentions": [], "contextBefore": "...ou know, presentations to the board of directors, type of thing, right?\n[Speaker 8583913747141573407]: So, very simplistic cartoony type of presentations that deliver a very basic message but are on the same project that, you know, yesterday, we were talking and typing the details on.\n[Speaker 8583913747141573407]: So, yeah, Yeah, its just its context and group dependent, But we, you know, we have meetings that are all of us together.\n[Speaker 8583913747141573407]: We have meetings that are separate.\n[Speaker 8583913747141573407]: We have meetings that are bigger, you know, bigger.\n[Speaker 7797531502773666908]: Okay.\n[Speaker 7797531502773666908]: And then final question along this line of your group structure here, For each of those three groups you identified, do you have like a rough number of how many people are in each?\n[Speaker 7797531502773666908]: Is it like 10 each?\n[Speaker 7797531502773666908]: Is it 50?\n[Speaker 8583913747141573407]: No, no.\n[Speaker 8583913747141573407]: ", "contextAfter": "\n[Speaker 8583913747141573407]: Okay.\n[Speaker 8583913747141573407]: So that might be, it might be bigger than that, But yeah, you can roughly chop that in thirds as a guesstimate.\n[Speaker 8583913747141573407]: So maybe thats 60 or so people per focus area.\n[Speaker 7797531502773666908]: Okay.\n[Speaker 7797531502773666908]: And then how many people do you interact with on a like daily basis from your immediate group?\n[Speaker 7797531502773666908]: Is there kind of a core group that youre, always working on projects with Or are you cross functional with everyone in the group?\n[Speaker 8583913747141573407]: On a day to day basis, probably kind of a core set of 10 to 12 people.\n[Speaker 8583913747141573407]: Okay?\n[Speaker 8583913747141573407]: Either thats cross functional through project teams or just my immediate team here, which is six.\n[Speaker 8583913747141573407]: And then, you know, on the larger side, it can be up to, you know, 40, 50, 60 people at a time.\n[Speaker 8583913747141...", "callTitle": "User Interview with BioRender (Abbvie)"}], "confidence": "medium", "status": "auto_matched"}, "children": [{"id": "blood-cancer-discovery", "name": "Blood Cancers (Hematologic Malignancies)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "aml-discovery", "name": "Acute Myeloid Leukemia (AML)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "all-discovery", "name": "Acute Lymphoblastic Leukemia (ALL)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "lymphoma-discovery", "name": "Lymphoma", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "myeloma-discovery", "name": "Multiple Myeloma", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "solid-tumor-discovery", "name": "Solid Tumors", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "lung-cancer-discovery", "name": "Lung Cancer", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "gi-cancer-discovery", "name": "Gastrointestinal Cancers", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "tumor-biology-mechanisms", "name": "Tumor Biology & Mechanisms", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "neuroscience-discovery", "name": "Neuroscience Discovery", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "alzheimers-discovery", "name": "Alzheimer's Disease", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "parkinsons-discovery", "name": "Parkinson's Disease", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "neuropsychiatry-discovery", "name": "Neuropsychiatry", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "movement-disorders-discovery", "name": "Movement Disorders (including PSP)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "multiple-sclerosis-discovery", "name": "Multiple Sclerosis", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "eye-care-discovery", "name": "Eye Care Discovery", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "retinal-diseases-discovery", "name": "Chronic Retinal Diseases", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "neurodegenerative-retina", "name": "Neurodegenerative Diseases of the Retina", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "ocular-surface-diseases", "name": "Ocular Surface Diseases", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "glaucoma-discovery", "name": "Glaucoma", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "specialty-discovery", "name": "Specialty Diseases Discovery", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "virology-discovery", "name": "Virology (HCV, HIV)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "pulmonology-discovery", "name": "Pulmonology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "endocrinology-obesity", "name": "Endocrinology & Obesity", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "gi-hepatology", "name": "GI/Hepatology (including MASH)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "target-discovery-validation", "name": "Target Discovery & Validation", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "functional-genomics-discovery", "name": "Functional Genomics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "target-validation-biology", "name": "Target Validation Biology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "disease-modeling-discovery", "name": "Disease Modeling", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "discovery-platforms", "name": "Discovery Platforms & Modalities", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "small-molecule-discovery", "name": "Small Molecule Discovery", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "medicinal-chemistry-discovery", "name": "Medicinal Chemistry", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "computational-chemistry", "name": "Computational Chemistry", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "biologics-discovery", "name": "Biologics Discovery", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "antibody-discovery", "name": "Antibody Discovery & Engineering", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "bispecifics-discovery", "name": "Bispecific Antibodies", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "adc-discovery", "name": "Antibody-Drug Conjugates (ADCs)", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "genetic-medicines-discovery", "name": "Genetic Medicines", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "sirna-discovery", "name": "siRNA Therapeutics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "gene-therapy-discovery", "name": "Gene Therapy", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "drug-delivery-platforms", "name": "Drug Delivery Platforms", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "in-vitro-pharmacology", "name": "In Vitro Pharmacology", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "In vitro pharmacology?", "date": "2024-12-05", "gongUrl": "https://app.gong.io/call?id=125e832d5817c29dce9b0751e4f27b4a56dc4da556e82802f9381d4ef14aaa27", "callId": "2024-12-05_125e832d5817", "customerName": "Kushali Gupta", "internalName": "Sierra Barnes", "customerEmail": "kushali.gupta@abbvie.com", "internalEmail": "sierra.barnes@biorender.com", "speakerId": "6179994184188977843", "sizeMentions": [], "contextBefore": "...84188977843]: Yep.\n[Speaker 6179994184188977843]: We're so, we're part of AbbVie now, right?\n[Speaker 6179994184188977843]: So, we, we're AbbVie, but, we're just like it's slowly, we're just part of getting part of the integration process.\n[Speaker 6179994184188977843]: So, we were like, I think 300, 400 employees.\n[Speaker 6179994184188977843]: We were like small big companies, I guess, but, yeah.\n[Speaker 6179994184188977843]: So, I think AbbVie already has BioRender, it's just a matter of getting access.\n[Speaker 6179994184188977843]: So that's just the, just waiting on getting access to it, That's the only thing, Yeah.\n[Speaker 4810991605803478140]: I see.\n[Speaker 4810991605803478140]: Mm, hmm.\n[Speaker 4810991605803478140]: Mm.\n[Speaker 4810991605803478140]: Hmm.\n[Speaker 4810991605803478140]: Yeah, for sure.\n[Speaker 4810991605803478140]: And are you part of a specific department currently?\n[Speaker 4810991605803478140]: Like, does it have a name?\n[Speaker 6179994184188977843]: ", "contextAfter": "\n[Speaker 4810991605803478140]: I see.\n[Speaker 4810991605803478140]: And how many people in that team roughly would you say?\n[Speaker 6179994184188977843]: 1,520.\n[Speaker 4810991605803478140]: Okay, perfect.\n[Speaker 4810991605803478140]: I can give you some like context on our partnership now, but you are correct.\n[Speaker 4810991605803478140]: We do have like a centrally managed license with AbbVie right now And we're trying to figure out like who it makes sense to like get access to that and like, or that's like part of this like the inspiration for the call.\n[Speaker 4810991605803478140]: And one thing that we've done for other groups which I think might be helpful here is hosting a short team based webinar.\n[Speaker 4810991605803478140]: We've launched like a ton of new features in the last couple months, really like geared towards industry presentations.\n[Speaker 4810991605803478140]: We were like chatting with a lot of folks to hear what would be important to you guys.\n[Speake...", "callTitle": "Call with Abbvie - Kushali Gupta"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "in-vivo-pharmacology", "name": "In Vivo Pharmacology", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Jonathon Sedgwick", "title": "Senior Vice President and Global Head of Discovery Research"}}, {"id": "genomics-research-center", "name": "Genomics Research Center", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "we have our Genomics Research Center", "date": "2024-12-17", "gongUrl": "https://app.gong.io/call?id=d79c9aa23cd48aaf3afccfb51289b88516879fae0b538ef9b6e9e414cadc5a3a", "callId": "2024-12-17_d79c9aa23cd4", "customerName": "Thomas Lynch", "internalName": "Adrian Rizos; Tim Fung", "customerEmail": "thomas.lynch@abbvie.com", "internalEmail": "adrian.rizos@biorender.com; tim@biorender.com", "speakerId": "5305939227543161604", "sizeMentions": [], "contextBefore": "...No worries.\n[Speaker 5305939227543161604]: Likewise.\n[Speaker 5162156361298948043]: And I say we Tim's actually sick today.\n[Speaker 5162156361298948043]: So he's yeah, me and my buddy the note taker.\n[Speaker 5162156361298948043]: Yeah, Tim's actually sick today.\n[Speaker 5162156361298948043]: So he messaged me that he wasn't going to be able to join, but I appreciate you making it work.\n[Speaker 5305939227543161604]: Yeah, absolutely.\n[Speaker 5305939227543161604]: So really quick.\n[Speaker 5305939227543161604]: So, I think I jumped the gun a bit on the mentioning the file sharing.\n[Speaker 5305939227543161604]: I have to go.\n[Speaker 5305939227543161604]: I had to get it approved before I can send it Overall.\n[Speaker 5305939227543161604]: I mean, it's going to be largely Discovery and Development Sciences which is pretty much all of our scientists but, you know, we have on site here.\n[Speaker 5305939227543161604]: It's a lot of oncology and immuno oncology teams and our, you know, ", "contextAfter": ".\n[Speaker 5305939227543161604]: So that's going to be kind of the bulk of the, and, as well as some development teams like toxicology, and pathology, and then like our DMPK type of\u2026 roles.\n[Speaker 5305939227543161604]: So all those are relevant.\n[Speaker 5305939227543161604]: And then there are, you know, of course, non scientific roles as well, but those that might benefit from BioRender.\n[Speaker 5305939227543161604]: So I think once we have the, once we have the list and if I can get that approved, which I think I can because it came as like, you know, low risk information just to share department names, I think we should be, you know, have a better idea then of which groups you guys want to target when you come on site and then we can, this gives us time then in January to really get those meetings set up and kind of, you know, make it really good sessions.\n[Speaker 5162156361298948043]: Yeah, yeah, for sure.\n[Speaker 5162156361298948043]: And thanks for doing that homework and w...", "callTitle": "AbbVie & BioRender - Feb Onsite Planning"}], "confidence": "medium", "status": "auto_matched"}, "children": [{"id": "bioinformatics-genomics", "name": "Bioinformatics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "genomic-technologies", "name": "Genomic Technologies", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "human-genetics", "name": "Human Genetics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "functional-genomics-grc", "name": "Functional Genomics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "genomic-medicine", "name": "Genomic Medicine", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "genome-biology", "name": "Genome Biology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Howard Jacob", "title": "Vice President, Genetics Research & Data Convergence"}}, {"id": "development", "name": "Development", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "immunology-development", "name": "Immunology Development", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "oncology-development", "name": "Oncology Development", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "neuroscience-development", "name": "Neuroscience Development", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "eye-care-development", "name": "Eye Care Development", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [], "leader": {"name": "Mike Robinson", "title": "Vice President, Clinical Development, Ophthalmology"}}, {"id": "specialty-development", "name": "Specialty Development", "type": "therapeutic_area", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "clinical-operations-dev", "name": "Clinical Operations", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "clinical-trial-management-dev", "name": "Clinical Trial Management", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "site-management-dev", "name": "Site Management & Monitoring", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "biostatistics-dev", "name": "Biostatistics", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "data-management-dev", "name": "Data Management", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "regulatory-affairs", "name": "Regulatory Affairs", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "regulatory-strategy", "name": "Regulatory Strategy", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "regulatory-submissions", "name": "Regulatory Submissions", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "rd-quality-assurance", "name": "R&D Quality Assurance", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "patient-safety", "name": "Patient Safety & Pharmacovigilance", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Neil Gallagher", "title": "Chief Medical Officer and Vice President of Development"}}, {"id": "precision-medicine", "name": "Precision Medicine & Translational Research", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": ["200"], "sizeMentions": [], "snippets": [{"quote": "So within precision medicine, I guess we have around 200. So that encompasses the entire precision medicine.", "date": "2025-01-07", "gongUrl": "https://app.gong.io/call?id=bacb7760d563764b5fcc6a6cc2b664369d67e1c07640ad8c566ee110affe7184", "callId": "2025-01-07_bacb7760d563", "customerName": "Pearlie Burnette", "internalName": "Adrian Rizos; Sierra Barnes", "customerEmail": "pk.eplingburnette@abbvie.com", "internalEmail": "adrian.rizos@biorender.com; sierra.barnes@biorender.com", "speakerId": "7827556866924301789", "sizeMentions": [], "contextBefore": "...oma which is also, you know, close to being approved, for multiple myeloma indications.\nSo these are late stage assets.\nWe used to work on.\nMy team used to cover also the teliso, v and\u2026 An ABBV4 zero zero, which is a antibody drug conjugate with a TOPE1 payload.\nSo we have a combination of ADCs and T cell engagers.\nBut now it'll be more immunotherapy related assets and heme assets that are T cell engagers primarily.\nSo yeah, that's our team and we support In IND enabling studies.\nSo in the lab, we do things that are needed for the IND applications or we do provide supporting data for patient selection, combinations, mechanisms of resistance.\nThose are the kind of things that we're dealing with.\nOkay.\nAwesome.\nAnd so you have a team of 11 plus yourself.\nSo a group of 12 in total.\nYeah.\nOkay.\nAnd then you mentioned that, so you, your team rolls up to the oncology group, How large is the oncology group?\nApproximately, just out of curiosity?\nSo we're the precision medicine oncology group.\n", "contextAfter": "\nOkay?\nCool.\nAnd it sounds like in terms of the work that you're doing, it sounds like a lot, you're working quite a bit with other teams within precision medicine and even outside of precision medicine as well.\nOutside.\nAnd, you know, we work with earlier development teams as well as OED.\nSo we work with clinical teams, We work with, yeah, it's very cross functional.\nSo we, because we provide translational data, we have to be engaged with the clinical teams as well as with the discovery teams, you know?\nSo we have a lot of different interactions.\nOkay.\nSounds great.\nAnd then can you just give me a high level understanding of how you're currently communicating your science like visually and like what types of tools, but also like what types of meetings are you usually involved in?\nI imagine a lot of internal meetings, cross department meetings, things like that.\nBut can you just give me a bit of a lay of the land of how that looks today?\nYes.\nSo I would say internally, it would be as y...", "callTitle": "BioRender & AbbVie - Intro Call"}], "confidence": "medium", "status": "auto_matched"}, "children": [{"id": "precision-medicine-oncology", "name": "Precision Medicine Oncology", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "translational-oncology", "name": "Translational Research Oncology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "oncology-biomarkers", "name": "Oncology Biomarker Development", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "translational-genomics-oncology", "name": "Translational Research Genomics", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "precision-medicine-immunology", "name": "Precision Medicine Immunology", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "translational-immunology", "name": "Translational Research Immunology", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "companion-diagnostics", "name": "Companion Diagnostics", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "biomarker-sciences", "name": "Biomarker Sciences", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Ian McCaffery", "title": "Vice President, Global Head of Precision Medicine, Translational Research & Companion Diagnostics"}}, {"id": "aesthetics-rd", "name": "Allergan Aesthetics R&D", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "neurotoxins-rd", "name": "Neurotoxins R&D", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "dermal-fillers-rd", "name": "Dermal Fillers R&D", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "body-aesthetics-rd", "name": "Body Aesthetics R&D", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "energy-devices-rd", "name": "Energy-Based Devices R&D", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "migraine-research", "name": "Migraine Research", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Darin Messina", "title": "Senior Vice President, Global Head of Aesthetics R&D"}}, {"id": "pharmaceutical-sciences", "name": "Pharmaceutical Sciences & Development Sciences", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "drug-product-development", "name": "Drug Product Development", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "formulation-development", "name": "Formulation Development", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "And then we will need formulation development", "date": "2024-10-25", "gongUrl": "https://app.gong.io/call?id=39eeff6ff150077b7264eda77d5b1d2f2d82bb27f3ebed35d52ec92a9ee361ba", "callId": "2024-10-25_39eeff6ff150", "customerName": "", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "jiabao.wen@abbvie.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "speakerId": "6175632510978732353", "sizeMentions": [], "contextBefore": "...year.\n[Speaker 6175632510978732353]: So, I think its close to just within the cell culture.\n[Speaker 6175632510978732353]: If you consider an entire CMC, I think its close to maybe, Im, not too sure.\n[Speaker 6175632510978732353]: Dont quote me on that like 100 to 200 people.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And you said teen one five is your subculture group?\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: Ok.\n[Speaker 6225769224974612910]: So CMC is about 100 to 200.\n[Speaker 6225769224974612910]: Your specific group is around 15.\n[Speaker 6225769224974612910]: Whats whats like the group?\n[Speaker 6225769224974612910]: Is there a group breakdown or are there like category groups of different groups?\n[Speaker 6175632510978732353]: So within CMC, we have before us cell line development, and then cell culture development, and then purification development.\n[Speaker 6175632510978732353]: And then we will need analytical development, ", "contextAfter": ".\n[Speaker 6175632510978732353]: And then we have our clinical team regulatory team.\n[Speaker 6175632510978732353]: Yeah, pretty much thats it.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And could you remind me whats the name of your group?\n[Speaker 6225769224974612910]: Because CMC is the entire 100 to 200 people.\n[Speaker 6225769224974612910]: And the name of your group is, how do you define your group?\n[Speaker 6225769224974612910]: The 15 folks?\n[Speaker 6175632510978732353]: The cell culture development?\n[Speaker 6225769224974612910]: Cell culture development?\n[Speaker 6225769224974612910]: Sorry, Cell culture development.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: I see.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: So cell line development is before you, then its your group.\n[Speaker 6225769224974612910]: And then you have purification analytical formulation.\n[Speaker 6225769224974612910]: Yes.\n[Speaker 6225...", "callTitle": "User Interview with BioRender (Abbvie)"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "drug-product-design", "name": "Drug Product Design", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "process-chemistry", "name": "Process Chemistry", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "solid-state-chemistry", "name": "Solid State Chemistry", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "process-engineering", "name": "Process Engineering", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "So under that, it's process engineering, but I don't know if that's the official group.", "date": "2025-05-14", "gongUrl": "https://app.gong.io/call?id=5c6d0949c2e4401077ac38fa6f31177d891d883b8d8ed99a5f888f0ab85f8ade", "callId": "2025-05-14_5c6d0949c2e4", "customerName": "Ricardo Sosa", "internalName": "Michael Long; Michelle Jang", "customerEmail": "ricardo.sosa@abbvie.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "speakerId": "9158548807244643977", "sizeMentions": [], "contextBefore": "...nd see, you know, if they think that they can find some utility out of this.\n[Speaker 9158548807244643977]: If so, then, I, you know, I think personally that it could be pretty useful, but obviously we need to get, you\u2026 know, more feedback from the broader group?\n[Speaker 3808181939226083287]: Yeah, absolutely.\n[Speaker 3808181939226083287]: I'd be actually curious.\n[Speaker 3808181939226083287]: I'm going to take a quick look just to see we have pretty high level visibility into the actual users at abbvie.\n[Speaker 3808181939226083287]: I don't get a ton of good insight.\n[Speaker 3808181939226083287]: They're pretty restrictive on who has access to like, you know, user information, but we do see that some people like self report what groups they're a part of.\n[Speaker 3808181939226083287]: I know that Michelle noted that you're within like product development, science and technology.\n[Speaker 3808181939226083287]: Do you have like a specific group name?\n[Speaker 9158548807244643977]: ", "contextAfter": "\n[Speaker 3808181939226083287]: Name.\n[Speaker 3808181939226083287]: Okay.\n[Speaker 3808181939226083287]: Yeah, because yeah, even like looking through this like process science research, I see 15 users.\n[Speaker 3808181939226083287]: I see another three user group.\n[Speaker 3808181939226083287]: I see another five user group.\n[Speaker 3808181939226083287]: So there's definitely folks within like product development or process engineering that have access right now.\n[Speaker 3808181939226083287]: And so what, you know, the question is are there other users that don't know about this?\n[Speaker 3808181939226083287]: Maybe they're in a similar situation as you.\n[Speaker 3808181939226083287]: They're new to the group or they didn't get on the last request that might want access.\n[Speaker 3808181939226083287]: And, you know, like I said, what we find is making that as a group request, you know, is a better business case for abbvie to approve this.\n[Speaker 3808181939226083287]: But if not, ...", "callTitle": "BioRender & AbbVie - Follow Up Call"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "biologics-development-sciences", "name": "Biologics Development Sciences", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "cell-line-development", "name": "Cell Line Development", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 2, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "So, we are the cell line development team within product development, science and technology.", "date": "2024-12-05", "gongUrl": "https://app.gong.io/call?id=8cbe981f63db80fe87164141034b987387b25fe0143390628093627f034a7e1b", "callId": "2024-12-05_8cbe981f63db", "customerName": "Deanna Follit", "internalName": "Sierra Barnes", "customerEmail": "deanna.follit@abbvie.com", "internalEmail": "sierra.barnes@biorender.com", "speakerId": "3321987900836973065", "sizeMentions": [], "contextBefore": "...03940985]: Hmm.\n[Speaker 8079842019903940985]: Mm.\n[Speaker 8079842019903940985]: Hmm.\n[Speaker 8079842019903940985]: Yeah, I know science can get so nuanced and like the details, you know, really mattered if you know, so it's important that they don't you know, necessarily slip through the cracks, but which, which department are you in at AbbVie?\n[Speaker 3321987900836973065]: The department is technically, hold on one second.\n[Speaker 3321987900836973065]: What's our new name.\n[Speaker 3321987900836973065]: We keep changing our name.\n[Speaker 3321987900836973065]: I don't want to give you the wrong name.\n[Speaker 8079842019903940985]: Thank you.\n[Speaker 3321987900836973065]: Yeah.\n[Speaker 3321987900836973065]: Okay.\n[Speaker 3321987900836973065]: So, it's now product development, science and technology.\n[Speaker 3321987900836973065]: It's technically the entire department, but there's like, I don't know at least five subgroups within that department.\n[Speaker 3321987900836973065]: ", "contextAfter": "\n[Speaker 8079842019903940985]: Mm.\n[Speaker 8079842019903940985]: Hmm.\n[Speaker 8079842019903940985]: Okay.\n[Speaker 8079842019903940985]: Long names.\n[Speaker 8079842019903940985]: How many people would you say are in cell and development?\n[Speaker 3321987900836973065]: Yes.\n[Speaker 3321987900836973065]: About 25.\n[Speaker 8079842019903940985]: 25 people.\n[Speaker 8079842019903940985]: Okay?\n[Speaker 8079842019903940985]: And curious if you guys are like collaborating at all in like how you're building out your figures, like, what does that process look like?\n[Speaker 3321987900836973065]: No, It's no, it's normally like, I would say as collaborative as it gets is, hey, you had this presentation, you had this figurine, can I have it, Like that's about it?\n[Speaker 8079842019903940985]: No, not at all.\n[Speaker 8079842019903940985]: Okay.\n[Speaker 8079842019903940985]: Take a screenshot of it.\n[Speaker 8079842019903940985]: Yeah, asking because we do have some collaborative features ...", "callTitle": "Call with Abbvie - Deanna Follit"}, {"quote": "So within CMC, we have before us cell line development", "date": "2024-10-25", "gongUrl": "https://app.gong.io/call?id=39eeff6ff150077b7264eda77d5b1d2f2d82bb27f3ebed35d52ec92a9ee361ba", "callId": "2024-10-25_39eeff6ff150", "customerName": "", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "jiabao.wen@abbvie.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "speakerId": "6175632510978732353", "sizeMentions": [], "contextBefore": "...s illustration.\n[Speaker 6175632510978732353]: Not so much on the molecular side of things.\n[Speaker 6175632510978732353]: Yeah, But our group here consists of actually, we grow in size quite a lot this year.\n[Speaker 6175632510978732353]: So, I think its close to just within the cell culture.\n[Speaker 6175632510978732353]: If you consider an entire CMC, I think its close to maybe, Im, not too sure.\n[Speaker 6175632510978732353]: Dont quote me on that like 100 to 200 people.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And you said teen one five is your subculture group?\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: Ok.\n[Speaker 6225769224974612910]: So CMC is about 100 to 200.\n[Speaker 6225769224974612910]: Your specific group is around 15.\n[Speaker 6225769224974612910]: Whats whats like the group?\n[Speaker 6225769224974612910]: Is there a group breakdown or are there like category groups of different groups?\n[Speaker 6175632510978732353]: ", "contextAfter": ", and then cell culture development, and then purification development.\n[Speaker 6175632510978732353]: And then we will need analytical development, And then we will need formulation development.\n[Speaker 6175632510978732353]: And then we have our clinical team regulatory team.\n[Speaker 6175632510978732353]: Yeah, pretty much thats it.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And could you remind me whats the name of your group?\n[Speaker 6225769224974612910]: Because CMC is the entire 100 to 200 people.\n[Speaker 6225769224974612910]: And the name of your group is, how do you define your group?\n[Speaker 6225769224974612910]: The 15 folks?\n[Speaker 6175632510978732353]: The cell culture development?\n[Speaker 6225769224974612910]: Cell culture development?\n[Speaker 6225769224974612910]: Sorry, Cell culture development.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: I see.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: So...", "callTitle": "User Interview with BioRender (Abbvie)"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "upstream-processing", "name": "Upstream Processing", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "downstream-processing", "name": "Downstream Processing", "type": "team", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "analytical-development", "name": "Analytical Development", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 1, "teamSizes": [], "sizeMentions": [], "snippets": [{"quote": "And then we will need analytical development", "date": "2024-10-25", "gongUrl": "https://app.gong.io/call?id=39eeff6ff150077b7264eda77d5b1d2f2d82bb27f3ebed35d52ec92a9ee361ba", "callId": "2024-10-25_39eeff6ff150", "customerName": "", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "jiabao.wen@abbvie.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "speakerId": "6175632510978732353", "sizeMentions": [], "contextBefore": "...of actually, we grow in size quite a lot this year.\n[Speaker 6175632510978732353]: So, I think its close to just within the cell culture.\n[Speaker 6175632510978732353]: If you consider an entire CMC, I think its close to maybe, Im, not too sure.\n[Speaker 6175632510978732353]: Dont quote me on that like 100 to 200 people.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And you said teen one five is your subculture group?\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: Ok.\n[Speaker 6225769224974612910]: So CMC is about 100 to 200.\n[Speaker 6225769224974612910]: Your specific group is around 15.\n[Speaker 6225769224974612910]: Whats whats like the group?\n[Speaker 6225769224974612910]: Is there a group breakdown or are there like category groups of different groups?\n[Speaker 6175632510978732353]: So within CMC, we have before us cell line development, and then cell culture development, and then purification development.\n[Speaker 6175632510978732353]: ", "contextAfter": ", And then we will need formulation development.\n[Speaker 6175632510978732353]: And then we have our clinical team regulatory team.\n[Speaker 6175632510978732353]: Yeah, pretty much thats it.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: And could you remind me whats the name of your group?\n[Speaker 6225769224974612910]: Because CMC is the entire 100 to 200 people.\n[Speaker 6225769224974612910]: And the name of your group is, how do you define your group?\n[Speaker 6225769224974612910]: The 15 folks?\n[Speaker 6175632510978732353]: The cell culture development?\n[Speaker 6225769224974612910]: Cell culture development?\n[Speaker 6225769224974612910]: Sorry, Cell culture development.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: I see.\n[Speaker 6225769224974612910]: Okay.\n[Speaker 6225769224974612910]: So cell line development is before you, then its your group.\n[Speaker 6225769224974612910]: And then you have purification analytical formulation.\n[S...", "callTitle": "User Interview with BioRender (Abbvie)"}], "confidence": "medium", "status": "auto_matched"}, "children": []}, {"id": "combination-products-devices", "name": "Combination Products & Devices", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [], "leader": {"name": "Joan Byrne", "title": "Vice President, Product Development Science And Technology - Combination Products And Devices"}}, {"id": "manufacturing-science-technology", "name": "Manufacturing Science & Technology", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}, {"id": "medical-affairs", "name": "Medical Affairs", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "medical-information", "name": "Medical Information", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "scientific-communications", "name": "Scientific Communications", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "health-economics-outcomes", "name": "Health Economics & Outcomes Research", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "real-world-evidence-medical", "name": "Real-World Evidence", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}], "leader": {"name": "Latif Murji", "title": "Senior Vice President, Medical Affairs and Health Economics Outcomes Research"}}, {"id": "rd-operations-strategy", "name": "R&D Operations & Strategy", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "rd-strategic-planning", "name": "R&D Strategic Planning", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "portfolio-management-rd", "name": "Portfolio Management", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "business-development-search-evaluation", "name": "Search & Evaluation and Global Alliances", "type": "department", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [], "leader": {"name": "Niels Emmerich", "title": "Vice President, Global Head Search & Evaluation and Global Alliances"}}]}, {"id": "global-rd-sites", "name": "Global R&D Sites", "type": "division", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": [{"id": "north-chicago-il", "name": "North Chicago, IL (Global Headquarters & Primary R&D Hub)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "irvine-ca", "name": "Irvine, CA (Allergan Aesthetics Center of Excellence)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "worcester-ma", "name": "Worcester, MA (AbbVie Bioresearch Center)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "cambridge-crossing-ma", "name": "Cambridge Crossing, MA (Neuroscience Hub)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "waltham-ma", "name": "Waltham Area, MA (Oncology Center of Excellence)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "south-san-francisco-ca", "name": "South San Francisco, CA (Biotech Corridor Hub)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "ludwigshafen-germany", "name": "Ludwigshafen, Germany (Integrated R&D & Manufacturing)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}, {"id": "tokyo-japan", "name": "Tokyo, Japan (Clinical Development)", "type": "site", "level": 0, "sites": [], "notes": "", "gongEvidence": {"matchedEntities": [], "matchedContacts": [], "totalMentions": 0, "teamSizes": [], "sizeMentions": [], "snippets": [], "confidence": "none", "status": "unverified"}, "children": []}]}], "leader": {"name": "Roopal Thakkar", "title": "Executive Vice President, Research & Development and Chief Scientific Officer"}}}